Amalgamated Bank Amicus Therapeutics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
 - Q3 2025
 
A detailed history of Amalgamated Bank transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 9,021 shares of FOLD stock, worth $81,459. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,021
              Previous 10,224
              
        
           11.77%
        
      
          
        Holding current value
$81,459
            Previous $58,000
            
        
           22.41%
        
      
          
        % of portfolio
0.0%
            Previous 0.0%
          
        Shares
	  30 transactions
	
  Others Institutions Holding FOLD
# of Institutions
307Shares Held
332MCall Options Held
396KPut Options Held
249K- 
    
      Vanguard Group Inc Valley Forge, PA29.4MShares$266 Million0.0% of portfolio
 - 
    
      Wellington Management Group LLP Boston, MA29.1MShares$263 Million0.03% of portfolio
 - 
    
      Black Rock Inc. New York, NY24.4MShares$220 Million0.01% of portfolio
 - 
    
      Avoro Capital Advisors LLC New York, NY18MShares$163 Million1.88% of portfolio
 - 
    
      William Blair Investment Management, LLC Chicago, IL14.6MShares$132 Million0.24% of portfolio
 
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 280,497,984
 - Market Cap $2.53B
 - Description
 - Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...